Literature DB >> 11115250

The rise and fall of bromide therapy in epilepsy.

W J Friedlander1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115250     DOI: 10.1001/archneur.57.12.1782

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  7 in total

1.  The potential value of discordant studies.

Authors:  Mark Doyle
Journal:  Cardiovasc Diagn Ther       Date:  2014-02

Review 2.  Treatment Strategies for Dravet Syndrome.

Authors:  Kelly G Knupp; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

3.  Bromide Dose in Dogs With Epilepsy Living Close to Coastal Areas and Living More Inland: A Retrospective Observational Study.

Authors:  Esther A Lichtenauer; Bas Evers; Jan van den Broek; Paul J J Mandigers
Journal:  Front Vet Sci       Date:  2022-05-13

Review 4.  Recent Advances in the Drug Treatment of Dravet Syndrome.

Authors:  Elaine C Wirrell; Rima Nabbout
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

5.  DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy.

Authors:  J Song; L Parker; L Hormozi; M A Tanouye
Journal:  Neuroscience       Date:  2008-07-23       Impact factor: 3.590

Review 6.  New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?

Authors:  Jacqueline A French; Deana M Gazzola
Journal:  Ther Adv Drug Saf       Date:  2011-08

7.  Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents.

Authors:  David C Henshall; Nick Dürmüller; H Steve White; Robert Williams; Paul Moser; Mark Dunleavy; Peter H Silverstone
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.